Age is an individual risk factor for not being referred to adjuvant chemotherapy in patients resected for UICC III colorectal cancer: a nationwide cohort study

References

• Sanoff HK, Carpenter WR, Stürmer T, et al. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol. 2012;30(21):2624–2634.
   PubMed Web of Science ®Google Scholar
• Bergquist JR, Thiels CA, Spindler BA, et al. Benefit of postresection adjuvant chemotherapy for stage III colon cancer in octogenarians. Dis Colon Rectum. 2016;59(12):1142–1149.
   PubMed Web of Science ®Google Scholar
• Hung A, Mullins CD. Relative effectiveness and safety of chemotherapy in elderly and nonelderly patients with stage III colon cancer: a systematic review. Oncologist. 2013;18(1):54–63.
   PubMed Web of Science ®Google Scholar
• Papamichael D, Audisio R, Horiot J-C, et al. Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. Ann Oncol. 2009;20(1):5–16.
   PubMed Web of Science ®Google Scholar
• Lund CM, Nielsen D, Dehlendorff C, et al. Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colorectal cancer: the ACCORE study. ESMO Open. 2016;1(5):e000087.
   PubMed Web of Science ®Google Scholar
• Kahn KL. Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA. 2010;303(11):1037.
   PubMed Web of Science ®Google Scholar
• Serra-Rexach JA, Jimenez AB, García-Alhambra MA, et al. Differences in the therapeutic approach to colorectal cancer in young and elderly patients. Oncologist. 2012;17(10):1277–1285.
   PubMed Web of Science ®Google Scholar
• Christensen K, Thinggaard M, Oksuzyan A, et al. Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart. Lancet. 2013;382(9903):1507–1513.
   PubMed Web of Science ®Google Scholar
• Partridge L, Deelen J, Slagboom PE. Facing up to the global challenges of ageing. Nature. 2018;561(7721):45–56.
   PubMed Web of Science ®Google Scholar
• Iversen LH, Green A, Ingeholm P, et al. Improved survival of colorectal cancer in Denmark during 2001–2012 – the efforts of several national initiatives. Acta Oncol. 2016;55(Suppl. 2):10–23.
   PubMed Web of Science ®Google Scholar
• Weerink LBM, Gant CM, van Leeuwen BL, et al. Long-term survival in octogenarians after surgical treatment for colorectal cancer: prevention of postoperative complications is key. Ann Surg Oncol. 2018;25(13):3874–3882.
   PubMed Web of Science ®Google Scholar
• Ingeholm P, Gögenür I, Iversen L. Danish Colorectal Cancer Group Database. Clin Epidemiol. 2016;8:465–468.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Ostenfeld EB, Nørgaard M, Thomsen RW, et al. Comorbidity and survival of Danish patients with colon and rectal cancer from 2000–2011: a population-based cohort study. Clin Epidemiol. 2013;5(Suppl. 1):65–74.
   PubMedGoogle Scholar
• Iversen LH, Nørgaard M, Jacobsen J, et al. The impact of comorbidity on survival of Danish colorectal cancer patients from 1995 to 2006—a population-based cohort study. Dis Colon Rectum. 2009;52(1):71–78.
   PubMed Web of Science ®Google Scholar
• Baretti M, Rimassa L, Personeni N, et al. Effect of comorbidities in stage II/III colorectal cancer patients treated with surgery and neoadjuvant/adjuvant chemotherapy: a single-center, observational study. Clin Colorectal Cancer. 2018;17(3):e489–e498.
   PubMed Web of Science ®Google Scholar
• Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–655.
   PubMed Web of Science ®Google Scholar
• Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457.
   PubMed Web of Science ®Google Scholar
• Bojer AS, Roikjær O. Elderly patients with colorectal cancer are oncologically undertreated. Eur J Surg Oncol. 2015;41(3):421–425.
   PubMed Web of Science ®Google Scholar
• Winget M, Hossain S, Yasui Y, et al. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment. Cancer. 2010;116(20):4849–4856.
   PubMed Web of Science ®Google Scholar
• Luo R, Giordano SH, Freeman JL, et al. Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer. Oncologist. 2006;11(9):1025–1033.
   PubMed Web of Science ®Google Scholar
• QUASAR Collaborative Group. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007;370:2020–2029.
   PubMed Web of Science ®Google Scholar
• Nitsche U, Stöss C, Friess H. Effect of adjuvant chemotherapy on elderly colorectal cancer patients: lack of evidence. Gastrointest Tumors. 2017;4(1–2):11–19.
   PubMed Web of Science ®Google Scholar
• Lavanchy JL, Vaisnora L, Haltmeier T, et al. Oncologic long-term outcomes of emergency versus elective resection for colorectal cancer. Int J Colorectal Dis. 2019;34(12):2091–2099.
   PubMed Web of Science ®Google Scholar
• Wanis KN, Ott M, Van Koughnett JAM, et al. Long-term oncological outcomes following emergency resection of colon cancer. Int J Colorectal Dis. 2018;33(11):1525–1532.
   PubMed Web of Science ®Google Scholar
• Osagiede O, Spaulding AC, Cochuyt JJ, et al. Factors associated with minimally invasive surgery for colorectal cancer in emergency settings. J Surg Res. 2019;243:75–82.
   PubMed Web of Science ®Google Scholar
• Degett TH, Dalton SO, Christensen J, et al. Mortality after emergency treatment of colorectal cancer and associated risk factors—a nationwide cohort study. Int J Colorectal Dis. 2019;34(1):85–95.
   PubMed Web of Science ®Google Scholar
• Lemmens V, van Halteren AH, Janssen-Heijnen MLG, et al. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol. 2005;16(5):767–772.
   PubMed Web of Science ®Google Scholar
• El Shayeb M, Scarfe A, Yasui Y, et al. Reasons physicians do not recommend and patients refuse adjuvant chemotherapy for stage III colon cancer: a population based chart review. BMC Res Notes. 2012;5:269.
   PubMedGoogle Scholar